Paragraph 2

Changes not yet applied. Later legislation changes this provision in ways not yet written into the text below:

Sch 7, para 2 am by Medicines (Products for Animal Use—Fees) 2001 reg 2(1), (8)(a)
Sch 7, para 4 am by Medicines (Products for Animal Use—Fees) 2001 reg 2(1), (8)(b)
regs 12,13.14. Sch 1. Pt.II, paras.1 -3,6-9, Pt.III. paras 4,5, Pt.IV, paras.1- 3,5-7, Pt.V, paras.1 -3. Sch.2. paras.2.3 amended by Medicines (Products for Animal Use—Fees) 2000 reg.2. Sch.
Sch 7, para 4 am by Medicines (Products for Animal Use—Fees) 2003 regs 3(1), (6), 4

The relevant authority may waive or reduce the payment of any fee payable under these Regulations in circumstances where–

(a)

in its opinion the interests of human or animal health require a marketing authorisation, product licence or certificate to be granted or an inspection to be made; and

(b)

the product in respect of which an application for a marketing authorisation, product licence or certificate has been made–

(i)

it is not intended for sale; or

(ii)

is intended only for use in the treatment of rare conditions or in the treatment of a minor species of animal or as an emergency vaccine.